Abstract: The present invention concerns a sterile closed loop device for medical-surgical use intended for the collection, the transportation and the processing of prostheses and/or biological samples and the like, having at least one collection compartment provided with an hermetically closable main opening, for the introduction of said prosthesis and/or biological samples and the like to be analyzed, so as to be contained in it, at least one containment chamber, in which a solution is contained for the chemical detachment of bacteria adhering to animate or inanimate surfaces, such as prostheses and the like, and/or bacterial biofilm, said containment chamber being selectively communicating with said collection compartment, so that said solution can be conveyed from said containment chamber to said collection compartment, for the chemical separation of bacteria to said prosthesis and/or biological samples and the like to be analyzed, that can be inserted in said collection compartment, and extraction means of said so

Abstract: The present invention relates to a composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system. In particular, the present invention relates to the use of selected probiotic bacteria for the preparation of a composition for the treatment of allergies, such as atopic dermatitis.

Abstract: The present invention concerns a sterile closed loop device for medical-surgical use intended for the collection, the transportation and the processing of prostheses and/or biological samples and the like, having at least one collection compartment provided with an hermetically closable main opening, for the introduction of said prosthesis and/or biological samples and the like to be analyzed, so as to be contained in it, at least one containment chamber, in which a solution is contained for the chemical detachment of bacteria adhering to animate or inanimate surfaces, such as prostheses and the like, and/or bacterial biofilm, said containment chamber being selectively communicating with said collection compartment, so that said solution can be conveyed from said containment chamber to said collection compartment, for the chemical separation of bacteria to said prosthesis and/or biological samples and the like to be analyzed, that can be inserted in said collection compartment, and extraction means of said so

Abstract: The present invention relates to a composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system. In particular, the present invention relates to the use of selected probiotic bacteria for the preparation of a composition for the treatment of allergies, such as atopic dermatitis.

Abstract: The present invention relates to an implantable paste comprising bioactive glass powder having a size distribution of 0.5-45 ?m, bioactive glass granules having a size distribution between 100 and 4000 ?m, low molecular weight polyethylene glycol having a molecular weight range of 200-700 g/mol, medium molecular weight polyethylene glycol having a molecular weight range of 700-2500 g/mol, high molecular weight polyethylene glycol having a molecular weight range of 2500-8000 g/mol and glycerol. The composition of the bioactive glass is 45-55 weight-% of SiO2, 20-25 weight-% of Na2O, 18-25 weight-% of CaO and 3-6 weight-% of P2O5, and the molecular weight of the low molecular weight polyethylene glycol and of the medium molecular weight polyethylene glycol differ from each other by at least 80 g/mol and that the molecular weight of the medium molecular weight polyethylene glycol and of the high molecular weight polyethylene glycol differ from each other by at least 300 g/mol.

Abstract: The present invention relates to a composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system. In particular, the present invention relates to the use of selected probiotic bacteria for the preparation of a composition for the treatment of allergies, such as atopic dermatitis.

Abstract: The present invention relates to a composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system. In particular, the present invention relates to the use of selected probiotic bacteria for the preparation of a composition for the treatment of allergies, such as atopic dermatitis.

Abstract: The present invention relates to a composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system. In particular, the present invention relates to the use of selected probiotic bacteria for the preparation of a composition for the treatment of allergies, such as atopic dermatitis.

Abstract: The present invention relates to a composition comprising probiotic bacteria for the treatment of pathologies associated with alterations of the immune system. In particular, the present invention relates to the use of selected probiotic bacteria for the preparation of a composition for the treatment of allergies, such as atopic dermatitis.

Abstract: Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful for the treatment Chlamydia pneumoniae infections is described.

Abstract: Use of thiamphenicol and derivatives thereof for the preparation of pharmaceutical compositions useful for the treatment Chlamydia pneumoniae infections is described.